Page last updated: 2024-10-24

cetyltrimethylammonium ion and Eye Cancer, Retinoblastoma

cetyltrimethylammonium ion has been researched along with Eye Cancer, Retinoblastoma in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Research Excerpts

ExcerptRelevanceReference
" This paper suggests that the choice of the concentration of a cationic agent is critical when formulating a safe and stable LN."1.40Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity. ( Andreani, T; Egea, MA; Fangueiro, JF; Garcia, ML; Silva, AM; Souto, EB; Souto, SB, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fangueiro, JF1
Andreani, T1
Egea, MA1
Garcia, ML1
Souto, SB1
Silva, AM1
Souto, EB1

Other Studies

1 other study available for cetyltrimethylammonium ion and Eye Cancer, Retinoblastoma

ArticleYear
Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.
    International journal of pharmaceutics, 2014, Jan-30, Volume: 461, Issue:1-2

    Topics: Administration, Ophthalmic; Cations; Cell Line, Tumor; Cetrimonium; Cetrimonium Compounds; Chemistry

2014